According to Zhitong Finance App, Ruili Medical & Aesthetic (02135.HK) announced that the Group expects to record revenue of approximately RMB 115 million for the six months ending June 30, 2026, and approximately RMB 85 million for the six months ending June 30, 2025; and the Group expects to record profit attributable to shareholders of the parent company for the six months ending June 30, 2026, of approximately RMB 4 million, while the six months ended June 30, 2025 recorded a loss attributable to shareholders of the parent company.

According to Zhitong Finance App, Ruili Medical & Aesthetic (02135.HK) announced that the Group expects to record revenue of approximately RMB 115 million for the six months ending June 30, 2026, and approximately RMB 85 million for the six months ending June 30, 2025; and the Group expects to record profit attributable to shareholders of the parent company for the six months ending June 30, 2026, of approximately RMB 4 million, while the six months ended June 30, 2025 recorded a loss attributable to shareholders of the parent company.